Guide: How to cite a Press release in JBCS style

Guide: How to cite a Press release in JBCS style

Cite A Press release in JBCS style

Ads keep us free. Upgrade to remove.

Use the following template to cite a press release using the JBCS citation style. For help with other source types, like books, PDFs, or websites, check out our other guides. To have your reference list or bibliography automatically made for you, try our free citation generator.

Key:

Pink text = information that you will need to find from the source.
Black text = text required by the JBCS style.

Reference list

Place this part in your bibliography or reference list at the end of your assignment.

Template:

1.Title; Year Published.

Example:

1.Kogan, N.; Mechoulam, R. ;Dialogues in Clinical Neuroscience 2007, 9.

In-text citation

Place this part right after the quote or reference to the source in your assignment.

Template

1

Example

Many drugs used today can cause addiction and are misused and abused, for example opiates,265 cocaine,266 benzodiazepines,267 barbiturates,268 cholinergic agonists,269 ketamine,270,271 dopaminergic agonists,272 amphetamines,273 and others. Nevertheless they are still an important part of our pharmacopeia. Marijuana was used for centuries as a medicinal plant, but during the last century, because of its abuse and addictive potential it was taken out of clinical practice. Now, we believe that its constituents and related compounds should be brought back to clinical use. The reasons are: (i) the therapeutic potential of CB1 agonists is huge, as described in this review; (ii) for local action, topical CB1 agonists, or agonists that do not penetrate the blood-brain barrier, can be used; (iii) cannabinoids acting specifically on CB2 receptors, which cause no psychoactivity, may be used on peripheral targets (such as osteoporosis,274,275 which is only one of many examples); (iv) there are additional, new cannabinoid targets distinct from the CB1/CB2 receptors276-278 which do not cause psychoactivity; (v) there are cannabinoids, such as CBD, which do not cause psychoactivity, but have various therapeutic effects.

The endocannabinoid system is a very complex one and regulates numerous processes, in parallel with other wellknown systems, such as the adrenergic, cholinergic, and dopaminergic systems. Neglecting the potential clinical uses of such a system is, in our view, unacceptable; instead we need to work on more selective agonists/antagonists, more selective distribution patterns, and in cases where it is impossible to separate between the desired clinical action and the psychoactivity, to monitor these side effects carefully. 1

Popular JBCS Citation Guides


Other JBCS Citation Guides

Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!!

  • ✔ Save your bibliographies for longer
  • ✔ Super fast and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Use our extensive Premium features (Plagiarism checks, Word Add On...)
  • ✔ Create and edit multiple bibliographies
Join